Last reviewed · How we verify

NCT03201276

Individual Differences in Glucosamine Sulfate Exposure Levels

Status unknown Last updated 5 July 2017
What this trial tests

trial testing Glucosamine Sulfate in Knee Osteoarthritis in 400 participants. Status unknown.

Timeline
2 July 2017
Primary endpoint
1 July 2019
1 October 2019

Quick facts

Lead sponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date2 July 2017
Primary completion1 July 2019
Estimated completion1 October 2019

Drugs / interventions tested

Conditions studied

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Who can join

Adults 60 to 80, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glucosamine is an important part of the treatment strategy for osteoarthritis, but its effectiveness is still controversial. To explain the efficacy differences of glucosamine, in this study the investigators detect the concentration of glucosamine in the plasma and synovial fluid, some effect indexes such as inflammatory markers and gene polymorphism of glucosamine transporters. On the one hand, the investigators compare the plasma peak and gluten glucosamine concentration and the concentration in synovial fluid among participants to observe the individual differences of glucosamine exposure in vivo. On the other hand, the investigators investigate the correlation between drug concentrations, effect index and gene polymorphism. The hypothesis is that glucosamine exposure in vivo has individual differences and gene polymorphism can explain this differences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Glucosamine Sulfate

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03201276.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing